Form D Explorer

Inspect source fieldsReport a record issue

Form D/A — BTB Therapeutics, Inc.

0002055053-26-000003 · filed Aug 12, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$10,402,704
Reported amount sold
$8,902,204
Minimum investment
$0
Investors
4
Sales commission
$0
Finders' fees
$0

Issuer

Name
BTB Therapeutics, Inc.
CIK
2055053
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2024
Address
26281 WYNDEMERE COURT
ESCONDIDO, California 92026
Phone
(858) 945-3733

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗